Peptide CDMO Market, Global Outlook and Forecast 2024-2031

Peptide CDMO
This report contains market size and forecasts of Peptide CDMO in Global, including the following market information:
Global Peptide CDMO Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Peptide CDMO market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
LPPS Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peptide CDMO include Thermo Fisher Pharma, PolyPeptide, Bachem, ScinoPharm, CBL, AmbioPharm, Piramal Pharma, CordenPharma and CPC SCIENTIFIC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide CDMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide CDMO Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Peptide CDMO Market Segment Percentages, by Type, 2021 (%)
LPPS
SPPS
Mixed Phase
Global Peptide CDMO Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Peptide CDMO Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical Industry
Cosmetics Industry
Others
Global Peptide CDMO Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Peptide CDMO Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide CDMO revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Peptide CDMO revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Pharma
PolyPeptide
Bachem
ScinoPharm
CBL
AmbioPharm
Piramal Pharma
CordenPharma
CPC SCIENTIFIC
Provepharm
Space Peptides
Biopeptek
Alpha Biophama
Alabiochem
Aurigene Pharmaceutical Services
Chengdu Shengnuo Biotechnology Co., Ltd
Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd